Woodline Partners LP
Institutional investor · Portfolio as of Q1 2022
Top Holdings709 positions
SEAGEN INC | 1.4M | $202.8M | 3.3% | — | — | 6 qtrssince 2020-Q4 | Increased 90 |
SPDR S&P 500 ETF TRUST | 316,200 | $142.8M | 2.3% | — | — | — | Decreased — |
| 247,509 | $103.4M | 1.7% | $95.41 | +9.39% | 8 qtrssince 2020-Q2 | Increased 55 | |
ZYNGA INC - CL A | 11M | $102M | 1.7% | — | — | 1 qtr | New 68 |
BOSTON SCIENTIFIC CORP | 1.8M | $81.1M | 1.3% | $44.29 | 0.00% | 1 qtr | New 68 |
LAM RESEARCH CORP | 146,756 | $78.9M | 1.3% | $51.38 | 0.00% | 1 qtr | New 68 |
KLA CORP | 209,664 | $76.8M | 1.2% | $33.49 | +4.66% | 8 qtrssince 2020-Q2 | Increased 75 |
REGENERON PHARMACEUTICALS | 105,494 | $73.7M | 1.2% | $523.16 | +32.25% | 6 qtrssince 2020-Q4 | Increased 54 |
MERCK & CO. INC. | 869,391 | $71.3M | 1.2% | $71.52 | +0.28% | 5 qtrssince 2021-Q1 | Increased 75 |
DANAHER CORP | 238,140 | $69.9M | 1.1% | $232.35 | +9.27% | 9 qtrssince 2020-Q1 | Decreased 0 |
ALPHABET INC-CL A | 24,244 | $67.4M | 1.1% | $126.14 | +9.21% | 4 qtrssince 2021-Q2 | Decreased 0 |
STANLEY BLACK & DECKER INC | 481,778 | $67.3M | 1.1% | $134.87 | -8.19% | 2 qtrssince 2021-Q4 | Increased 75 |
PROCTER AND GAMBLE CO | 424,749 | $64.9M | 1.1% | $131.63 | +3.27% | 3 qtrssince 2021-Q3 | Increased 74 |
ARROW ELECTRONICS INC | 541,114 | $64.2M | 1.0% | $121.82 | -2.62% | 10 qtrssince 2019-Q4 | Increased 52 |
SPLUNK INC | 428,155 | $63.6M | 1.0% | — | — | 1 qtr | New 67 |
TE CONNECTIVITY LTD | 461,682 | $60.5M | 1.0% | $125.77 | -0.01% | 3 qtrssince 2021-Q3 | Increased 67 |
REVOLUTION MEDICINES INC | 2.3M | $59.5M | 1.0% | $30.00 | -14.69% | 7 qtrssince 2020-Q3 | Decreased 0 |
DELL TECHNOLOGIES -C | 1.2M | $57.9M | 0.9% | $49.04 | -7.03% | 3 qtrssince 2021-Q3 | Increased 56 |
CIGNA CORP NEW | 226,135 | $54.2M | 0.9% | $220.47 | 0.00% | 1 qtr | New 57 |
AT&T INC | 2.2M | $52.1M | 0.8% | $14.96 | -8.09% | 6 qtrssince 2020-Q4 | Increased 44 |
Woodline Partners LP manages $6.2B across 709 positions as of Q1 2022. Top holdings: SGEN (3.3%), SPY puts (2.3%), COO (1.7%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 2/5.0.
Active quarter - 217 new positions, 202 exits, 113 increased. Top move: SGEN (INCREASED, conviction 90). Portfolio: $6.2B across 709 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR